Sign In
Last checked at 
3 Mar 2009 17:26
Phytopharm plc
Annual Information Update
Phytopharm plc (the Company) announces that, in accordance with the requirements of Prospectus Rule 5.2 issued by the Financial Services Authority, and following publication of the Annual Report on 28 January 2009, the following information has been published or made available to the public between 3 February 2008 and 3 March 2009 inclusive, in compliance with laws and rules dealing with the regulation of securities, issuers of securities and securities markets.
For the purpose of this update, only references to the information are provided. Full copies of each item can be found at the locations specified below. In accordance with the provisions of Article 27.3 of the Prospectus Directive Regulations, we confirm that to the best of our knowledge, information relating to 'Holdings in Company' and 'Director/PDMR Shareholdings' is up to date at the date of this announcement, but it is acknowledged that such disclosures may, at any time, become out of date, due to changing circumstances.
1. Announcements made via Regulatory Information Services
All documents listed below were published via a regulatory information service on the dates indicated:
|
Date of publication |
Title |
|
5 February 2008 |
Total voting rights |
|
14 February 2008 |
Director / PDMR shareholding |
|
18 February 2008 |
Interim management statement |
|
28 February 2008 |
Notice of AGM |
|
3 March 2008 |
Total voting rights |
|
4 March 2008 |
Publication of prospectus |
|
13 March 2008 |
Director / PDMR shareholding |
|
25 March 2008 |
Placing and open offer |
|
27 March 2008 |
Result of AGM |
|
27 March 2008 |
Result of AGM |
|
28 March 2008 |
Director / PDMR shareholding |
|
28 March 2008 |
Director / PDMR shareholding |
|
28 March 2008 |
Director / PDMR shareholding |
|
28 March 2008 |
Director / PDMR shareholding |
|
28 March 2008 |
Director / PDMR shareholding |
|
28 March 2008 |
Director / PDMR shareholding |
|
28 March 2008 |
Director / PDMR shareholding |
|
28 March 2008 |
Holdings in Company |
|
1 April 2008 |
Total voting rights |
|
2 April 2008 |
Holdings in Company |
|
4 April 2008 |
Holdings in Company |
|
4 April 2008 |
Holdings in Company |
|
4 April 2008 |
Holdings in Company |
|
4 April 2008 |
Holdings in Company |
|
4 April 2008 |
Holdings in Company |
|
4 April 2008 |
Holdings in Company |
|
4 April 2008 |
Holdings in Company |
|
9 April 2008 |
Holdings in Company |
|
14 April 2008 |
Holdings in Company |
|
14 April 2008 |
Holdings in Company |
|
14 April 2008 |
Director / PDMR shareholding |
|
1 May 2008 |
Total voting rights |
|
2 May 2008 |
Block listing review |
|
12 May 2008 |
Director / PDMR shareholding |
|
16 May 2008 |
Notice of interim results |
|
21 May 2008 |
Myogane™ granted EU Orphan drug status |
|
29 May 2008 |
Interim results |
|
3 June 2008 |
Director / PDMR shareholding |
|
3 June 2008 |
Director / PDMR shareholding |
|
4 June 2008 |
Total voting rights |
|
11 June 2008 |
Product launch |
|
13 June 2008 |
Director / PDMR shareholding |
|
3 July 2008 |
Interim management statement |
|
9 July 2008 |
Director / PDMR shareholding |
|
21 July 2008 |
Price monitoring extension |
|
8 August 2008 |
Director / PDMR shareholding |
|
10 September 2008 |
Director / PDMR shareholding |
|
9 October 2008 |
Director / PDMR shareholding |
|
5 November 2008 |
Block listing interim review |
|
11 November 2008 |
Director / PDMR shareholding |
|
13 November 2008 |
Board change |
|
14 November 2008 |
Trading statement |
|
27 November 2008 |
Final results |
|
12 December 2008 |
Portfolio update |
|
19 December 2008 |
Price monitoring extension |
|
19 December 2008 |
Second price monitoring extension |
|
28 January 2009 |
Annual report and accounts & notice of AGM |
|
17 February 2009 |
Interim management statement |
|
17 February 2009 |
Holdings in Company |
|
19 February 2009 |
Holdings in Company |
2. Documents published or sent to Shareholders or filed with the UK Listing Authority or submitted to the FSA
|
Date of publication |
Title |
|
28 February 2008 |
Notice of AGM |
|
28 February 2008 |
Prospectus and notice of EGM |
|
28 February 2008 |
Form 1 Application for admission of securities to trading |
|
28 February 2008 |
Application for admission of securities to the Official List |
|
28 March 2008 |
Special resolutions passed at AGM |
|
28 March 2008 |
Special resolutions passed at EGM |
|
29 January 2009 |
Annual report 2008 |
|
29 January 2009 |
Notice of AGM |
Certain documents submitted to the FSA can be viewed at the Document Viewing Facility situated at the Financial Services Authority, 25 The North Colonnade, Canary Wharf, London E14 5HS
The 2008 Interim and 2008 Annual reports are also available on the Company's website www.phytopharm.com
3. Documents filed at Companies House
The Company has submitted the following filings to Companies House:
|
Date of Publications |
Title |
|
14 January 2008 |
Form 363 Annual Return |
|
24 January 2008 |
Form 88(2) Return of Allotments of Shares |
|
13 February 2008 |
Form 88(2) Return of Allotments of Shares |
|
13 March 2008 |
Form 88(2) Return of Allotments of Shares |
|
28 March 2008 |
Special resolutions passed at AGM |
|
28 March 2008 |
Special resolution passed at EGM |
|
28 March 2008 |
Form 123 Notice of Increase in Nominal Capital |
|
28 March 2008 |
Articles of Association |
|
2 April 2008 |
Form 88(2) Return of Allotments of Shares |
|
14 April 2008 |
Form 88(2) Return of Allotments of Shares |
|
13 May 2008 |
Form 88(2) Return of Allotment of Shares |
|
2 July 2008 |
Form 288b Terminating appointment of Company Secretary |
|
2 July 2008 |
Form 288a Appointment of Company Secretary |
|
14 November 2008 |
Form 288b Terminating appointment of Director - Dr D Rees |
|
14 November 2008 |
288b Terminating appointment of Director - Mr P Morgan |
|
10 December 2008 |
Form 363 Annual Return |
|
21 January 2009 |
Form 353a Notice of place for inspection of a register of members |
|
29 January 2009 |
Annual report and accounts for the year ended 30 September 2008 |
Copies of these documents can be obtained from Companies House, Crown Way, Cardiff CF14 3UZ (Telephone 0870 3333 636, email at enquiries @companies-house.gov.uk) or, if you are a registered user, through Companies House Direct at www.companies-house.gov.uk
Copies of all documents referred to above are also available for inspection at the Company's registered office (Corpus Christi House, 9 West Street, Godmanchester, Cambs PE29 2HY, United Kingdom) during normal business hours or by request from the Company Secretary.
For further information, please contact:
Zoe McGowan, Head of Finance
Phytopharm plc Tel No: +44 (0)1480 437697
Further information about Phytopharm can be found on the Company's website www.phytopharm.com
Follow the stocks
